1st Quarter - Report

HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) for HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)

Firm
Client
Income
—
Expenses
$232,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

LIFO Accounting Methodology; 1099 Reporting Requirement (H.R. 4, H.R. 705)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 705 (112th), H.R. 4 (112th)

Medicare/Medicaid MMM

Average Sales Price (H.R. 905/S. 733)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY New —
THOMAS PHAN Professional Staff, Senate Aging Committee

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 905 (112th), S. 733 (112th)

Budget/Appropriations BUD

H.J. Res. 44, Further Continuing Appropriations Amendments, 2011; H.J. Res 48, Additional continuing Appropriations Amendments, 20ll; H.R. 1363, Department of Defense and Further additional Continuing Appropriations Act, 2011; H.R. 1473, Final Fiscal Year 2011 Continuing Resolution; House Budget Resolution; H.R. 1, Full-Year Continuing Appropriations Act, 2011

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY New —

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1363 (112th), H.J.Res. 44 (112th), H.R. 1 (112th), H.R. 1473 (112th), H.J.Res. 48 (112th)

Pharmacy PHA

Importation of prescription drugs (S.319, H.R. 147); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation; NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065); Drug Abuse (S. 507); Drug Shortages (S. 296)

LobbyistCovered position, as disclosed
JEWELYN COSGROVE Intern, Senator Wayne Allard
KRISTEN FREITAS Director of Outreach, Congressman Dick Chrysler
ELIZABETH GALLENAGH Legislative Assistant, Representative Tom Manton
PATRICK MCANDREW KELLY New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 507 (112th), H.R. 147 (112th), S. 296 (112th), S. 319 (112th), H.R. 1065 (112th), H.R. 866 (112th)

Affiliated organisations

OrganisationLocation
AMERISOURCEBERGEN DRUG COMPANY Valley Forge, PA, US
CARDINAL HEALTH, INC. Dublin, OH, US
MCKESSON CORPORATION San Francisco, CA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.